Extracorporeal Membrane Oxygenation: Blood Cells
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/23/2016 |
| Start Date: | March 2015 |
| Contact: | Kari Emiley, BSN |
| Email: | kari.emiley@spectrumhealth.org |
| Phone: | 616-391-5752 |
The objective of the study is to predict outcomes of patients on extracorporeal membrane
oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to
clinical outcomes on ECMO using data collected in the ECMO Registry at Spectrum Health.
oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to
clinical outcomes on ECMO using data collected in the ECMO Registry at Spectrum Health.
ECMO group:
Inclusion Criteria:
- Greater than or equal to 18 years of age
- Subject presents to the CTICU at Butterworth Campus, Spectrum Health and is
critically ill in the ICU needing ECMO therapy.
Exclusion Criteria:
- Subject is less than18 years of age
- Known prisoner
Control Subjects:
Inclusion Criteria
- Greater than 18 years of age
- without any known cardiovascular, lung, or autoimmune disease.
Exclusion Criteria:
- Less than or equal to 18 years of age
- Known cardiovascular, lung, or autoimmune disease
We found this trial at
1
site
Click here to add this to my saved trials
